Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Foreign Bodies | 5 | 2018 | 104 | 1.240 |
Why?
|
| Magnets | 5 | 2018 | 22 | 1.210 |
Why?
|
| Play and Playthings | 2 | 2018 | 18 | 0.700 |
Why?
|
| Pancreatitis, Chronic | 2 | 2024 | 68 | 0.430 |
Why?
|
| Pancreatitis | 4 | 2024 | 128 | 0.430 |
Why?
|
| Child Welfare | 1 | 2014 | 64 | 0.430 |
Why?
|
| Deglutition | 2 | 2013 | 49 | 0.420 |
Why?
|
| Intestinal Perforation | 1 | 2012 | 59 | 0.390 |
Why?
|
| Nutritional Status | 1 | 2014 | 314 | 0.380 |
Why?
|
| Gastroenterology | 1 | 2014 | 190 | 0.360 |
Why?
|
| Recurrence | 2 | 2024 | 1427 | 0.350 |
Why?
|
| Societies, Medical | 1 | 2014 | 689 | 0.330 |
Why?
|
| Intestines | 1 | 2012 | 574 | 0.300 |
Why?
|
| Eating | 4 | 2018 | 375 | 0.270 |
Why?
|
| Algorithms | 1 | 2012 | 1616 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 1267 | 0.250 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2024 | 6 | 0.230 |
Why?
|
| Gene Transfer Techniques | 2 | 1997 | 357 | 0.220 |
Why?
|
| Gastrointestinal Tract | 2 | 2018 | 215 | 0.220 |
Why?
|
| Consumer Product Safety | 3 | 2018 | 29 | 0.210 |
Why?
|
| Hypertriglyceridemia | 1 | 2024 | 102 | 0.210 |
Why?
|
| Colonic Diseases | 1 | 2023 | 38 | 0.200 |
Why?
|
| Digestive System Abnormalities | 1 | 2023 | 35 | 0.200 |
Why?
|
| Intussusception | 1 | 2023 | 46 | 0.200 |
Why?
|
| Venoms | 2 | 2012 | 20 | 0.190 |
Why?
|
| Genetic Vectors | 2 | 1997 | 940 | 0.190 |
Why?
|
| Triglycerides | 1 | 2024 | 573 | 0.190 |
Why?
|
| Intestinal Mucosa | 2 | 1997 | 780 | 0.170 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 249 | 0.170 |
Why?
|
| Child | 11 | 2024 | 24463 | 0.150 |
Why?
|
| Child, Preschool | 10 | 2024 | 14054 | 0.150 |
Why?
|
| Peptides | 2 | 2012 | 794 | 0.150 |
Why?
|
| Hypoglycemic Agents | 2 | 2012 | 443 | 0.150 |
Why?
|
| Databases, Factual | 3 | 2018 | 1175 | 0.150 |
Why?
|
| Acute Disease | 4 | 2024 | 1108 | 0.130 |
Why?
|
| Endoscopy | 1 | 2018 | 281 | 0.130 |
Why?
|
| Feeding and Eating Disorders of Childhood | 1 | 2015 | 14 | 0.120 |
Why?
|
| Disabled Children | 1 | 2015 | 24 | 0.120 |
Why?
|
| Adenoviridae | 1 | 1997 | 605 | 0.110 |
Why?
|
| Laparotomy | 1 | 2015 | 135 | 0.110 |
Why?
|
| Retroviridae | 1 | 1994 | 198 | 0.110 |
Why?
|
| Household Articles | 1 | 2013 | 3 | 0.110 |
Why?
|
| Adolescent | 9 | 2024 | 19333 | 0.110 |
Why?
|
| Junctional Adhesion Molecules | 1 | 2013 | 2 | 0.110 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2015 | 241 | 0.110 |
Why?
|
| Enteral Nutrition | 1 | 2015 | 256 | 0.100 |
Why?
|
| Neodymium | 1 | 2012 | 6 | 0.100 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 1091 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 154 | 0.100 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2013 | 75 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2012 | 1272 | 0.100 |
Why?
|
| Esophagus | 1 | 2013 | 215 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 2015 | 709 | 0.090 |
Why?
|
| Male | 11 | 2024 | 61314 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2015 | 487 | 0.080 |
Why?
|
| Humans | 13 | 2024 | 124822 | 0.080 |
Why?
|
| United States | 5 | 2018 | 10876 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 724 | 0.080 |
Why?
|
| Female | 10 | 2024 | 66580 | 0.070 |
Why?
|
| Infant | 6 | 2023 | 12488 | 0.070 |
Why?
|
| Inflammation | 1 | 2013 | 1428 | 0.060 |
Why?
|
| beta-Galactosidase | 2 | 1997 | 145 | 0.060 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2024 | 17 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1328 | 0.040 |
Why?
|
| Incidence | 2 | 2018 | 3144 | 0.040 |
Why?
|
| Adult | 3 | 2012 | 29484 | 0.040 |
Why?
|
| Adenovirus E1 Proteins | 1 | 1997 | 2 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 1997 | 57 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 2902 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2024 | 16296 | 0.030 |
Why?
|
| Transgenes | 1 | 1997 | 337 | 0.030 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2015 | 52 | 0.030 |
Why?
|
| Quality of Life | 1 | 2024 | 1949 | 0.030 |
Why?
|
| Intestine, Small | 1 | 1997 | 313 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1994 | 129 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 1231 | 0.030 |
Why?
|
| Cell Count | 1 | 1994 | 252 | 0.030 |
Why?
|
| Health Transition | 1 | 2013 | 10 | 0.030 |
Why?
|
| Adherens Junctions | 1 | 2013 | 12 | 0.030 |
Why?
|
| Tight Junction Proteins | 1 | 2013 | 12 | 0.030 |
Why?
|
| Epithelium | 1 | 1994 | 362 | 0.030 |
Why?
|
| Vimentin | 1 | 2013 | 66 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 1997 | 683 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2012 | 90 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2012 | 138 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2013 | 168 | 0.020 |
Why?
|
| Child Behavior | 1 | 2013 | 230 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 1997 | 3061 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 731 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2013 | 389 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 757 | 0.020 |
Why?
|
| Rats | 1 | 1997 | 3693 | 0.020 |
Why?
|
| Mutation | 1 | 2024 | 5815 | 0.020 |
Why?
|
| Cell Line | 1 | 1994 | 2770 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2012 | 8189 | 0.020 |
Why?
|
| Mice | 2 | 1997 | 17747 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 777 | 0.020 |
Why?
|
| Young Adult | 2 | 2012 | 8993 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 1290 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 3729 | 0.010 |
Why?
|
| Animals | 2 | 1997 | 34195 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2539 | 0.010 |
Why?
|
| Aged | 2 | 2012 | 19697 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5156 | 0.010 |
Why?
|
| Middle Aged | 2 | 2012 | 26730 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 4786 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 3436 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 12342 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 10275 | 0.010 |
Why?
|